Protocol Writing, Review, IRB submission for: A Phase I/II Trial in Patients with Metastatic Gastrointestinal Epithelial Cancer Administering Tumor-Infiltrating Lymphocytes in which the Gene Encoding CISH was Inactivated Using the CRISPR/ Cas9 System

Project: Research project

Project Details

Description

Protocol Writing, Review, IRB submission for: A Phase I/II Trial in Patients with Metastatic Gastrointestinal Epithelial Cancer Administering Tumor-Infiltrating Lymphocytes in which the Gene Encoding CISH was Inactivated Using the CRISPR/ Cas9 System
StatusActive
Effective start/end date2/1/198/1/20

Funding

  • INTIMA CAPITAL, LLC

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.